49 related articles for article (PubMed ID: 30946857)
1. Arsenic trioxide blocked proliferation and cardiomyocyte differentiation of human induced pluripotent stem cells: Implication in cardiac developmental toxicity.
Bao Z; Han Z; Zhang B; Yu Y; Xu Z; Ma W; Ding F; Zhang L; Yu M; Liu S; Jin M; Yan G; Huang Q; Wang X; Hua B; Yang F; Li Y; Liu Y; Zagidullin N; Carvalho K; Li B; Wang N; Cai B
Toxicol Lett; 2019 Jul; 309():51-58. PubMed ID: 30946857
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of arsenic trioxide-mediated changes in human induced pluripotent stem cells (IPS).
Graham B; Stevens J; Wells P; Sims J; Rogers C; Leggett SS; Ekunwe S; Ndebele K
Int J Environ Res Public Health; 2014 Jul; 11(7):7524-36. PubMed ID: 25054231
[TBL] [Abstract][Full Text] [Related]
3. A synthetic DNA-binding inhibitor of SOX2 guides human induced pluripotent stem cells to differentiate into mesoderm.
Taniguchi J; Pandian GN; Hidaka T; Hashiya K; Bando T; Kim KK; Sugiyama H
Nucleic Acids Res; 2017 Sep; 45(16):9219-9228. PubMed ID: 28934500
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Potential of Delivering Arsenic Trioxide into HPV-Infected Cervical Cancer Cells Using Liposomal Nanotechnology.
Wang X; Li D; Ghali L; Xia R; Munoz LP; Garelick H; Bell C; Wen X
Nanoscale Res Lett; 2016 Dec; 11(1):94. PubMed ID: 26887578
[TBL] [Abstract][Full Text] [Related]
5. Abnormal Progenitor Cell Differentiation and Cardiomyocyte Proliferation in Hypoplastic Right Heart Syndrome.
Yu Y; Wang C; Ye S; Xu Z; Lin H; Texter K; Shukla V; Ghadiali S; Ma Q; Garg V; Zhao MT
Circulation; 2024 Mar; 149(11):888-891. PubMed ID: 38466780
[No Abstract] [Full Text] [Related]
6. Omics-Based Platform for Studying Chemical Toxicity Using Stem Cells.
Han Y; Zhao J; Huang R; Xia M; Wang D
J Proteome Res; 2018 Jan; 17(1):579-589. PubMed ID: 29261316
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity.
Ye D; Bao Z; Yu Y; Han Z; Yu Y; Xu Z; Ma W; Yuan Y; Zhang L; Xu Y; Ma T; Liu S; Gao X; Yan G; Huang Q; Wang X; Hua B; Yang F; Li Y; Cai B
Toxicology; 2020 Apr; 435():152422. PubMed ID: 32112805
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-208a-3p promotes osteosarcoma progression via targeting PTEN.
Fu Y; Wang Y; Bi K; Yang L; Sun Y; Li B; Liu Z; Zhang F; Li Y; Feng C; Bi Z
Exp Ther Med; 2020 Dec; 20(6):255. PubMed ID: 33178353
[TBL] [Abstract][Full Text] [Related]
9. Targeting LncDACH1 promotes cardiac repair and regeneration after myocardium infarction.
Cai B; Ma W; Wang X; Sukhareva N; Hua B; Zhang L; Xu J; Li X; Li S; Liu S; Yu M; Xu Y; Song R; Xu B; Yang F; Han Z; Ding F; Huang Q; Yu Y; Zhao Y; Wang J; Bamba D; Zagidullin N; Li F; Tian Y; Pan Z; Yang B
Cell Death Differ; 2020 Jul; 27(7):2158-2175. PubMed ID: 31969690
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration.
Gong R; Jiang Z; Zagidullin N; Liu T; Cai B
Signal Transduct Target Ther; 2021 Jan; 6(1):31. PubMed ID: 33500391
[TBL] [Abstract][Full Text] [Related]
11. Loss of m
Gong R; Wang X; Li H; Liu S; Jiang Z; Zhao Y; Yu Y; Han Z; Yu Y; Dong C; Li S; Xu B; Zhang W; Wang N; Li X; Gao X; Yang F; Bamba D; Ma W; Liu Y; Cai B
Pharmacol Res; 2021 Dec; 174():105845. PubMed ID: 34428587
[TBL] [Abstract][Full Text] [Related]
12. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.
Han Z; Wang X; Xu Z; Cao Y; Gong R; Yu Y; Yu Y; Guo X; Liu S; Yu M; Ma W; Zhao Y; Xu J; Li X; Li S; Xu Y; Song R; Xu B; Yang F; Bamba D; Sukhareva N; Lei H; Gao M; Zhang W; Zagidullin N; Zhang Y; Yang B; Pan Z; Cai B
Theranostics; 2021; 11(6):3000-3016. PubMed ID: 33456585
[TBL] [Abstract][Full Text] [Related]
13. Investigating the applicability domain of the hiPSC-based PluriLum assay: an embryotoxicity assessment of chemicals and drugs.
Treschow AF; Valente MJ; Lauschke K; Holst B; Andersen AR; Vinggaard AM
Arch Toxicol; 2024 Apr; 98(4):1209-1224. PubMed ID: 38311648
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide: applications, mechanisms of action, toxicity and rescue strategies to date.
Yan M; Wang H; Wei R; Li W
Arch Pharm Res; 2024 Mar; 47(3):249-271. PubMed ID: 38147202
[TBL] [Abstract][Full Text] [Related]
15. Contaminant Metals and Cardiovascular Health.
Lundin KK; Qadeer YK; Wang Z; Virani S; Leischik R; Lavie CJ; Strauss M; Krittanawong C
J Cardiovasc Dev Dis; 2023 Oct; 10(11):. PubMed ID: 37998508
[TBL] [Abstract][Full Text] [Related]
16. Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications-Are We on the Road to Success?
Correia CD; Ferreira A; Fernandes MT; Silva BM; Esteves F; Leitão HS; Bragança J; Calado SM
Cells; 2023 Jun; 12(13):. PubMed ID: 37443761
[TBL] [Abstract][Full Text] [Related]
17. Developmental Toxicity Studies: The Path towards Humanized 3D Stem Cell-Based Models.
Branco MA; Nunes TC; Cabral JMS; Diogo MM
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902285
[TBL] [Abstract][Full Text] [Related]
18. Effects of Sodium Arsenite on the Myocardial Differentiation in Mouse Embryonic Bodies.
Jeong S; Ahn C; Kwon JS; Kim K; Jeung EB
Toxics; 2023 Feb; 11(2):. PubMed ID: 36851018
[TBL] [Abstract][Full Text] [Related]
19. Energy metabolism disorder dictates chronic hypoxia damage in heart defect with tetralogy of fallot.
Liu L; Huang L; Yao L; Zou F; He J; Zhao X; Mei L; Huang S
Front Cardiovasc Med; 2022; 9():1096664. PubMed ID: 36741837
[TBL] [Abstract][Full Text] [Related]
20. ALKBH5-mediated m
Han Z; Xu Z; Yu Y; Cao Y; Bao Z; Gao X; Ye D; Yan G; Gong R; Xu J; Zhang L; Ma W; Wang X; Yang F; Lei H; Tian Y; Hu S; Bamba D; Li Y; Li D; Li C; Wang N; Zhang Y; Pan Z; Yang B; Cai B
Mol Ther Nucleic Acids; 2021 Dec; 26():22-33. PubMed ID: 34513291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
